Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
- PMID: 33538338
- DOI: 10.3322/caac.21660
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Abstract
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
Keywords: burden; cancer; epidemiology; incidence; mortality.
© 2021 American Cancer Society.
Similar articles
-
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. CA Cancer J Clin. 2018. PMID: 30207593
-
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. CA Cancer J Clin. 2024. PMID: 38572751
-
Global cancer statistics, 2012.CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4. CA Cancer J Clin. 2015. PMID: 25651787
-
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.Lancet Oncol. 2022 Jun;23(6):719-728. doi: 10.1016/S1470-2045(22)00270-4. Epub 2022 May 9. Lancet Oncol. 2022. PMID: 35550275 Review.
-
Global Burden of Urologic Cancers, 1990-2013.Eur Urol. 2017 Mar;71(3):437-446. doi: 10.1016/j.eururo.2016.10.008. Epub 2016 Oct 28. Eur Urol. 2017. PMID: 28029399 Review.
Cited by
-
Outcomes of first-line treatment and their association with pretreatment neutrophil-to-lymphocyte ratio in patients with advanced renal cell carcinoma: Insights from a tertiary care institute in Pakistan.Ecancermedicalscience. 2024 Sep 3;18:1753. doi: 10.3332/ecancer.2024.1753. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39430088 Free PMC article.
-
The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases.BMC Cancer. 2024 Oct 31;24(1):1343. doi: 10.1186/s12885-024-13110-y. BMC Cancer. 2024. PMID: 39482635 Free PMC article.
-
A comparative study of incidence, mortality and disability adjusted life years (DALYs) for leading cancers in BRICS countries.Ecancermedicalscience. 2024 Sep 19;18:1773. doi: 10.3332/ecancer.2024.1773. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39430096 Free PMC article. Review.
-
KRAS Gene Mutation Associated with Grade of Tumor Budding and Peripheral Immunoinflammatory Indices in Patients with Colorectal Cancer.Int J Gen Med. 2024 Oct 18;17:4769-4780. doi: 10.2147/IJGM.S487525. eCollection 2024. Int J Gen Med. 2024. PMID: 39440104 Free PMC article.
-
Effect of laterality on the postoperative survival of non-small cell lung cancer patients undergoing pneumonectomy.Transl Lung Cancer Res. 2024 Sep 30;13(9):2411-2423. doi: 10.21037/tlcr-24-700. Epub 2024 Sep 27. Transl Lung Cancer Res. 2024. PMID: 39430318 Free PMC article.
References
-
- Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. In press.
-
- World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. WHO; 2020. Accessed December 11, 2020. who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-l...
-
- Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509-538.
-
- Gersten O, Wilmoth JR. The cancer transition in Japan since 1951. Demogr Res. 2002;7:271-306.
-
- United Nations Development Programme (UNDP). Human Development Report 2019. Beyond Income, Beyond Averages, Beyond Today: Inequalities in Human Development in the 21st Century. UNDP; 2019. Accessed November 25, 2020. hdr.undp.org/en/content/human-development-report-2019
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical